Morphine reverses the effects of 1-methyl-4-phenylpyridinium in PC12 cells through activating PI3K/Akt

References

• Wang S, He H, Chen L, et al. Protective effects of salidroside in the MPTP/MPP(+)-induced model of Parkinson's disease through ROS-NO-related mitochondrion pathway. Mol Neurobiol. 2015;51:718–728.
   PubMed Web of Science ®Google Scholar
• Zeng XS, Jia JJ, Kwon Y, et al. The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease. Free Radic Biol Med. 2014;67:10–18.
   PubMed Web of Science ®Google Scholar
• Bai J, Nakamura H, Ueda S, et al. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest. J Biol Chem. 2004;279:38710–38714.
   PubMed Web of Science ®Google Scholar
• Smith PD, Crocker SJ, Jackson-Lewis V, et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA. 2003;100:13650–13655.
   PubMed Web of Science ®Google Scholar
• O'Hare MJ, Kushwaha N, Zhang Y, et al. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci. 2005;25:8954–8966.
   PubMed Web of Science ®Google Scholar
• Radulovic NS, Blagojevic PD, Randjelovic PJ, et al. The last decade of antinociceptive alkaloids: structure, synthesis, mechanism of action and prospect. Curr Top Med Chem. 2013;13:2134–2170.
   PubMed Web of Science ®Google Scholar
• Fadda P, Scherma M, Fresu A, et al. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse. 2003;50:1–6.
   PubMed Web of Science ®Google Scholar
• Boutrel BA. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol. 2008;154:343–357.
   PubMed Web of Science ®Google Scholar
• De Vries, TJ, Shippenberg TS. Neural systems underlying opiate addiction. J Neurosci. 2002;22:3321–3325.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Suzuki Y, Nagayasu K, et al. Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLoS One. 2011;6:e24865.
   PubMed Web of Science ®Google Scholar
• Madishetti S, Schneble N, König C, et al. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. Br J Pharmacol. 2014;171:3328–3337.
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Harischandra DS, et al. Targeted toxicants to dopaminergic neuronal cell death. Methods Mol Biol. 2015;1254:239–252.
   PubMedGoogle Scholar
• Lee JY, Lee NK. Up-regulation of cyclinD1 and Bcl2A1 by insulin is involved in osteoclast proliferation. Life Sci. 2014;114:57–61.
   PubMed Web of Science ®Google Scholar
• Bai J, Nakamura H, Hattori I, et al. Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci Lett. 2002;321:81–84.
   PubMed Web of Science ®Google Scholar
• Ke K, Shen J, Song Y, et al. Cdk5 contributes to neuronal apoptosis via promoting MEF2D phosphorylation in rat model of intracerebral hemorrhage. J Mol Neurosci. 2015;56:48–59.
   PubMed Web of Science ®Google Scholar
• Smith PD, Mount MP, Shree R, et al. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci. 2006;26:440–447.
   PubMed Web of Science ®Google Scholar
• Luo FC, Feng YM, Zhao L, et al. Thioredoxin-1 expression regulated by morphine in SH-SY5Y cells. Neurosci Lett. 2012;523:50–55.
   PubMed Web of Science ®Google Scholar
• Guo L, Li H, Liu H, et al. Involvement of STAT5a signaling in morphine-induced up-regulation of the cyclin D1. Biochem Pharmacol. 2009;77:1553–1560.
   PubMed Web of Science ®Google Scholar
• Salas E, Alonso E, Polanco MJ, et al. Differential regulation of Cdk5 and c-Fos expression by morphine in the brain of Lewis and Fischer 344 rat strains. Neuroscience. 2013;230:151–156.
   PubMed Web of Science ®Google Scholar
• Wang SD, Luo FC, Chen Y, et al. 1-methyl-4-phenylpyridinium ion induces endoplasmic reticulum stress through glycogen synthase kinase-3 beta activation in PC12 cells. Neural Regen Res. 2011;6:805–810.
   Web of Science ®Google Scholar
• Yan T, Rizak JD, Yang S, et al. Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. PLoS One. 2014;9:e88404.
   PubMed Web of Science ®Google Scholar
• Fujino G, Noguchi T, Takeda K, et al. Thioredoxin and protein kinases in redox signaling. Semin Cancer Biol. 2006;16:427–435.
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Matsumoto K, Gon Y, et al. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1999;258:443–447.
   PubMed Web of Science ®Google Scholar
• Zou J, Chen Z, Wei X, et al. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units. Cell Death Dis. 2017;8:e2854.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yan J, Zhou P, et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol. 2012;97:1–13.
   PubMed Web of Science ®Google Scholar
• Wei X, Gao H, Zou J, et al. Contra-directional coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for memantine-induced anti-inflammation and anti-mitochondrial impairment. Mol Neurobiol. 2016;53(9):5876–5892.
   PubMed Web of Science ®Google Scholar
• Gao H, Chen Z, Fu Y, et al. Nur77 exacerbates PC12 cellular injury in vitro by aggravating mitochondrial impairment and endoplasmic reticulum stress. Sci Rep. 2016;6:34403.
   PubMed Web of Science ®Google Scholar
• Ramos-Miguel A, García-Sevilla JA. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain. Neuroscience. 2012;215:17–30.
   PubMed Web of Science ®Google Scholar
• Liberatore GT, Jackson-Lewis V, Vukosavic S, et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999;5:1403–1409.
   PubMed Web of Science ®Google Scholar
• Xu YQ1, Long L, Yan JQ, et al. Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses. CNS Neurosci Ther. 2013;19:170–177.
   PubMed Web of Science ®Google Scholar
• Bogush A, Pedrini S, Pelta-Heller J, et al. AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. J Biol Chem. 2007;282:7352–7359.
   PubMed Web of Science ®Google Scholar
• Mairet-Coello G, Tury A, DiCicco-Bloom E. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J Neurosci. 2009;29:775–788.
   PubMed Web of Science ®Google Scholar